© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Enovis Corporation (ENOV) stock declined over -3.62%, trading at $22.90 on NYSE, down from the previous close of $23.76. The stock opened at $23.45, fluctuating between $22.14 and $23.93 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 22, 2026 | 24.01 | 24.80 | 23.38 | 23.76 | 906.03K |
| Apr 21, 2026 | 26.27 | 26.64 | 23.72 | 23.73 | 1.29M |
| Apr 20, 2026 | 26.06 | 26.79 | 25.99 | 26.27 | 515.02K |
| Apr 17, 2026 | 25.50 | 27.04 | 25.45 | 26.32 | 1.71M |
| Apr 16, 2026 | 25.38 | 25.95 | 25.16 | 25.20 | 757.14K |
| Apr 14, 2026 | 24.87 | 25.66 | 24.87 | 25.10 | 505.04K |
| Apr 13, 2026 | 24.17 | 25.20 | 24.01 | 24.86 | 782.45K |
| Apr 10, 2026 | 24.21 | 24.50 | 23.89 | 24.42 | 480.53K |
| Apr 09, 2026 | 23.56 | 24.02 | 23.10 | 24.00 | 547.25K |
| Apr 08, 2026 | 24.01 | 24.51 | 23.57 | 23.79 | 779.68K |
| Apr 07, 2026 | 22.68 | 23.01 | 22.18 | 22.52 | 558.71K |
| Apr 06, 2026 | 22.33 | 22.76 | 22.23 | 22.76 | 638.43K |
| Apr 02, 2026 | 22.75 | 23.69 | 22.16 | 22.64 | 508.34K |
| Apr 01, 2026 | 22.81 | 23.40 | 22.43 | 23.37 | 638.54K |
| Mar 31, 2026 | 22.14 | 22.87 | 21.59 | 22.75 | 838.59K |
| Mar 30, 2026 | 22.14 | 22.34 | 21.48 | 21.69 | 810.58K |
| Mar 27, 2026 | 23.30 | 23.60 | 21.80 | 21.82 | 636.39K |
| Mar 25, 2026 | 22.65 | 23.03 | 21.81 | 22.62 | 614.97K |
| Mar 24, 2026 | 22.15 | 22.72 | 21.66 | 22.11 | 579.08K |
| Mar 23, 2026 | 22.64 | 23.29 | 21.97 | 22.51 | 1.01M |
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
| Employees | 7367 |
| Beta | 1.6 |
| Sales or Revenue | $1.71B |
| 5Y Sales Change% | -0.658% |
| Fiscal Year Ends | December |
| Sector | Industrials |
| Industry | Industrial - Machinery |